Cancer Diagnostics & Biomarkers
Part of Healthcare - Oncology
 NTRA | Natera, Inc. Common Stock | $59.1b | $402.39 | -6.1% | 1.3M |
 GH | Guardant Health, Inc. Common Stock | $23.9b | $174.73 | -7.0% | 1.3M |
 CAI | Caris Life Sciences, Inc. Common Stock | $8.0b | $28.28 | -6.9% | 2.0M |
 GRAL | GRAIL, Inc. Common Stock | $6.4b | $139.75 | -8.8% | 1.1M |
 BLLN | BillionToOne, Inc. Class A Common Stock | $5.0b | $100.41 | -8.3% | 441.2K |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | $4.5b | $27.75 | -7.5% | 891.4K |
 VCYT | Veracyte, Inc. | $3.7b | $45.37 | -5.5% | 726.2K |
 NEO | NeoGenomics, Inc. | $2.4b | $16.98 | -12.4% | 2.1M |
 PSNL | Personalis, Inc. Common Stock | $1.7b | $15.98 | -2.1% | 1.8M |
 CSTL | Castle Biosciences, Inc. Common Stock | $1.1b | $34.02 | -7.2% | 131.4K |
 ANGO | AngioDynamics, Inc. | $0.6b | $14.77 | -4.6% | 184.1K |
 FLGT | Fulgent Genetics, Inc. Common Stock | $0.6b | $20.89 | -6.3% | 127.3K |
 TOI | The Oncology Institute, Inc. Common Stock | $0.5b | $5.19 | 0.0% | N/A |
 MYGN | Myriad Genetics Inc | $434.2m | $4.26 | -7.5% | 651.6K |
 BDSX | Biodesix, Inc. Common Stock | $292.5m | $28.45 | +1.6% | 49.3K |
 LUCD | Lucid Diagnostics Inc. Common Stock | $119.8m | $0.60 | +2.2% | 577.8K |
 QUCY | Quantum Cyber N.V. Ordinary Shares | $111.8m | $1.30 | -3.0% | 54.5K |
 MDXH | MDxHealth SA Ordinary Shares | $54.5m | $0.60 | +1.5% | 81.5K |
 SRTS | Sensus Healthcare, Inc | $49.1m | $2.96 | 0.0% | 1.0K |
 PRPO | Precipio, Inc. Common Stock | $41.4m | $23.93 | +0.4% | 12.7K |
 PAVM | PAVmed Inc. Common Stock | $22.9m | $2.73 | 0.0% | 12.0K |
 ADVB | Advanced Biomed Inc. Common Stock | $11.1m | $6.83 | 0.0% | 13.7K |
 ZCMD | Zhongchao Inc. Class A Ordinary Shares | $8.2m | $1.81 | 0.0% | 49.4K |
 VNRX | VolitionRx Limited | $7.1m | $0.24 | +3.7% | 214.3K |
 AIDX | 20/20 Biolabs, Inc. Common Stock | $4.9m | $0.34 | 0.0% | 21.6K |
 BIAF | bioAffinity Technologies, Inc. Common Stock | $3.6m | $6.14 | -1.5% | 183.6K |
 ALBT | Avalon GloboCare Corp. Common Stock | $3.5m | $0.28 | 0.0% | N/A |
 ONCO | Onconetix, Inc. Common Stock | $3.2m | $0.65 | -4.2% | 311.7K |